Clinical Trial Update: Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

View source ↗

Summary

A completed clinical trial evaluating maternal immunization with Boostrix to prevent pertussis in infants under 2 months in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis
• Whooping Cough

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Whooping Cough | Status: COMPLETED | Results posted: 2020-07-07